SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT |
SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT
| |
| | |
| | |
| | |
| |
| |
Nine Months
Ended September 30, 2024 | |
| |
($
in thousands) | |
| |
Healthcare
IT | | |
Medical
Practice Management | | |
Unallocated
Corporate Expenses | | |
Total | |
Net revenue | |
$ | 71,603 | | |
$ | 10,995 | | |
$ | - | | |
$ | 82,598 | |
Operating expenses: | |
| | | |
| | | |
| | | |
| | |
Direct operating costs | |
| 37,699 | | |
| 8,140 | | |
| - | | |
| 45,839 | |
Selling and marketing | |
| 4,785 | | |
| 24 | | |
| - | | |
| 4,809 | |
General and administrative | |
| 6,923 | | |
| 1,392 | | |
| 3,812 | | |
| 12,127 | |
Research and development | |
| 2,768 | | |
| - | | |
| - | | |
| 2,768 | |
Depreciation and amortization | |
| 10,638 | | |
| 247 | | |
| - | | |
| 10,885 | |
Loss
on lease terminations, unoccupied lease charges and restructuring costs | |
| 505 | | |
| - | | |
| - | | |
| 505 | |
Loss on lease terminations, unoccupied lease charges and restructuring costs | |
| 505 | | |
| - | | |
| - | | |
| 505 | |
Total
operating expenses | |
| 63,318 | | |
| 9,803 | | |
| 3,812 | | |
| 76,933 | |
Operating income (loss) | |
$ | 8,285 | | |
$ | 1,192 | | |
$ | (3,812 | ) | |
$ | 5,665 | |
| |
| | |
| | |
| | |
| |
| |
Three Months
Ended September 30, 2024 | |
| |
($
in thousands) | |
| |
Healthcare
IT | | |
Medical
Practice Management | | |
Unallocated
Corporate Expenses | | |
Total | |
Net revenue | |
$ | 24,302 | | |
$ | 4,244 | | |
$ | - | | |
$ | 28,546 | |
Operating expenses: | |
| | | |
| | | |
| | | |
| | |
Direct operating costs | |
| 12,445 | | |
| 2,975 | | |
| - | | |
| 15,420 | |
Selling and marketing | |
| 1,368 | | |
| 7 | | |
| - | | |
| 1,375 | |
General and administrative | |
| 2,321 | | |
| 481 | | |
| 1,576 | | |
| 4,378 | |
Research and development | |
| 800 | | |
| - | | |
| - | | |
| 800 | |
Depreciation and amortization | |
| 3,159 | | |
| 82 | | |
| - | | |
| 3,241 | |
Loss
on lease terminations, unoccupied lease charges and restructuring costs | |
| 67 | | |
| - | | |
| - | | |
| 67 | |
Loss
on lease terminations, unoccupied lease charges and restructuring costs | |
| 67 | | |
| - | | |
| - | | |
| 67 | |
Total
operating expenses | |
| 20,160 | | |
| 3,545 | | |
| 1,576 | | |
| 25,281 | |
Operating income (loss) | |
$ | 4,142 | | |
$ | 699 | | |
$ | (1,576 | ) | |
$ | 3,265 | |
| |
| | |
| | |
| | |
| |
| |
Nine Months
Ended September 30, 2023 | |
| |
($
in thousands) | |
| |
Healthcare
IT | | |
Medical
Practice Management | | |
Unallocated
Corporate Expenses | | |
Total | |
Net revenue | |
$ | 78,531 | | |
$ | 10,112 | | |
$ | - | | |
$ | 88,643 | |
Operating expenses: | |
| | | |
| | | |
| | | |
| | |
Direct operating costs | |
| 46,003 | | |
| 7,840 | | |
| - | | |
| 53,843 | |
Selling and marketing | |
| 7,503 | | |
| 26 | | |
| - | | |
| 7,529 | |
General and administrative | |
| 8,466 | | |
| 1,362 | | |
| 6,690 | | |
| 16,518 | |
Research and development | |
| 3,523 | | |
| - | | |
| - | | |
| 3,523 | |
Depreciation and amortization | |
| 10,013 | | |
| 269 | | |
| - | | |
| 10,282 | |
Loss on lease terminations and unoccupied lease charges | |
| 430 | | |
| - | | |
| - | | |
| 430 | |
Loss on lease terminations, unoccupied lease charges and restructuring costs | |
| 430 | | |
| - | | |
| - | | |
| 430 | |
Total
operating expenses | |
| 75,938 | | |
| 9,497 | | |
| 6,690 | | |
| 92,125 | |
Operating income (loss) | |
$ | 2,593 | | |
$ | 615 | | |
$ | (6,690 | ) | |
$ | (3,482 | ) |
| |
| | |
| | |
| | |
| |
| |
Three Months
Ended September 30, 2023 | |
| |
($
in thousands) | |
| |
Healthcare
IT | | |
Medical
Practice Management | | |
Unallocated
Corporate Expenses | | |
Total | |
Net revenue | |
$ | 25,592 | | |
$ | 3,688 | | |
$ | - | | |
$ | 29,280 | |
Operating expenses: | |
| | | |
| | | |
| | | |
| | |
Direct operating costs | |
| 15,369 | | |
| 2,891 | | |
| - | | |
| 18,260 | |
Selling and marketing | |
| 2,329 | | |
| 8 | | |
| - | | |
| 2,337 | |
General and administrative | |
| 2,719 | | |
| 466 | | |
| 2,297 | | |
| 5,482 | |
Research and development | |
| 1,260 | | |
| - | | |
| - | | |
| 1,260 | |
Depreciation and amortization | |
| 3,814 | | |
| 89 | | |
| - | | |
| 3,903 | |
Loss on lease terminations and unoccupied lease charges | |
| 8 | | |
| - | | |
| - | | |
| 8 | |
Loss on lease terminations, unoccupied lease charges and restructuring costs | |
| 8 | | |
| - | | |
| - | | |
| 8 | |
Total
operating expenses | |
| 25,499 | | |
| 3,454 | | |
| 2,297 | | |
| 31,250 | |
Operating income (loss) | |
$ | 93 | | |
$ | 234 | | |
$ | (2,297 | ) | |
$ | (1,970 | ) |
|